Stay updated on Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.
Latest updates to the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew features have been added to the website, while several options related to participant groups, interventions, and data download formats have been removed.SummaryDifference4%
- Check36 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics, breast cancer, and clinical trials.SummaryDifference0.5%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to genetics and breast cancer, including links to MedlinePlus and ClinicalTrials.gov.SummaryDifference5%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Radiotherapy in Metastatic TNBC Clinical Trial page.